Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Diverse groups of experts helped assess the relationships between drivers on an extended time-horizon: assessing either no connection, some connection or a strong connection between two drivers along any of their possible future trajectories.
This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
ECDC works together with the institutions and agencies of the EU, in particular the European Commission’s Directorate-General for Health and Food Safety (DG SANTE), the European Food Safety Authority (EFSA), the European Medicines Agency (EMA), and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.